Rights and permissions
About this article
Cite this article
Cancer drugs: time to rethink clinical endpoints?. Pharmacoecon. Outcomes News 367, 2 (2002). https://doi.org/10.1007/BF03279187
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279187